New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds

<p>THURSDAY, Apr 19 (HealthDay News) Newer, some-more expensive
medications dont work most improved for a ongoing inflammatory skin
disease famous as psoriasis than a customary treatment, a new study
indicates.
The researchers found that biologics, that can cost upwards of $10,000
a year, were somewhat some-more effective than a customary drug diagnosis for
psoriasis, methotrexate, though that their impact lessened over time.
The commentary yield customarily singular wish for psoriasis sufferers, who
sometimes stop normal treatments since of revulsion and other bad
reactions.
When one looks during a outcome as being clear, or roughly transparent [skin],
the biologics seem to be some-more effective than methotrexate, pronounced study
author Dr. Joel Gelfand. But, when sum physique aspect area influenced by the
disease is combined in that disproportion diminishes, he said.
The study, published in a Apr emanate of a Archives of
Dermatology, was conducted from Feb 2010 by Jun 2011 i...